Access Pharmaceuticals, Inc. · Dallas, TX United States ·(OTC: ACCP)
Company Description
Phone: 214-905-5100
Fax: 214-905-5101
View Access Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Access Pharmaceuticals is looking for ways to give drugs direct and effective access to the parts of the body that need treatment. The company develops drug-delivery systems for application in cancer treatment. Oral treatment MuGard, which is used to reduce mouth inflammation in chemotherapy patients, has received marketing approval from the FDA. Its lead development product is ProLindac, a polymer platinate chemotherapy drug designed to target tumors. Other products in development include oral delivery systems and treatments for diabetes and cancer. The company added several anti-cancer candidates, including a monoclonal antibody, with the 2008 acquisition of Somanta Pharmaceuticals. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Access Pharmaceuticals, Inc. Financials
| Company Type | Public - OTC: ACCP Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $0.3 |
| 2008 Employees | 9 |
Access Pharmaceuticals, Inc. Executives
10 executives listed for Access Pharmaceuticals, Inc.'s Dallas, TX location.
| Title | Name & Bio | Contact |
| Chairman | Steven Rouhandeh | Network |
| Vice Chairman, Europe and Senior Director, Oncology Clinical Research and Development | Esteban Cvitkovic | Network |
| CEO and Director | Jeffrey Davis | Network |
Competition
Competitive Landscape for Access Pharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Access Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!